The 2x leveraged fund amplified a 27% gain in underlying stock QUBT following a significant price target hike from Ascendiant Capital Markets.
The Macau-based beverage importer's shares surged on unusually high volume without any clear news catalyst, raising questions among investors.
Shares surge on Nevada Tech Hub funding, a new charging technology patent, and an expanded partnership in the RV sector.
The semiconductor equipment giant faces significant headwinds as Washington tightens restrictions on technology exports to key Chinese customers.
The regional banking giant has now cleared all regulatory hurdles for its pending all-stock transaction with Veritex Holdings, set to close in 2025.
ProSense cryoablation system gains marketing authorization as the first minimally invasive treatment for low-risk tumors in women over 70.
Market reacts sharply to the newly combined company's strategic pivot from pharmaceuticals to HR technology and a new capital structure.
Zepzelca, in combination with Roche's Tecentriq, is the first approved first-line maintenance therapy for extensive-stage small cell lung cancer.